Immuneering (IMRX) Accumulated Depreciation & Amortization (2020 - 2024)
Historic Accumulated Depreciation & Amortization for Immuneering (IMRX) over the last 5 years, with Q3 2024 value amounting to $88949.0.
- Immuneering's Accumulated Depreciation & Amortization rose 1360.9% to $88949.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $88949.0, marking a year-over-year increase of 1360.9%. This contributed to the annual value of $322816.0 for FY2023, which is 2283.35% down from last year.
- Latest data reveals that Immuneering reported Accumulated Depreciation & Amortization of $88949.0 as of Q3 2024, which was up 1360.9% from $90533.0 recorded in Q2 2024.
- Immuneering's 5-year Accumulated Depreciation & Amortization high stood at $418337.0 for Q4 2022, and its period low was $54560.0 during Q2 2022.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $90533.0 (2024), whereas its average is $146551.1.
- As far as peak fluctuations go, Immuneering's Accumulated Depreciation & Amortization skyrocketed by 14012.13% in 2022, and later crashed by 6551.64% in 2023.
- Immuneering's Accumulated Depreciation & Amortization (Quarter) stood at $128752.0 in 2020, then soared by 35.31% to $174219.0 in 2021, then surged by 140.12% to $418337.0 in 2022, then decreased by 22.83% to $322816.0 in 2023, then tumbled by 72.45% to $88949.0 in 2024.
- Its Accumulated Depreciation & Amortization was $88949.0 in Q3 2024, compared to $90533.0 in Q2 2024 and $90209.0 in Q1 2024.